Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Gunn

Showing results (121-130 of 146) with videos related to

Pageof 15
Sort By:
European Journal of Preventive Cardiology|June 23, 2021
Is the SMART risk prediction model ready for real-world implementation? A validation study in a routine care setting of approximately 380 000 individualsAilsa J McKay, Laura H Gunn, Brian A Ference, et al.
Diagnostics (Basel, Switzerland)|February 24, 2024
A Novel Method for Assessing Risk-Adjusted Diagnostic Coding Specificity for Depression Using a U.S. Cohort of over One Million PatientsAlexandra Glass, Nalander C Melton, Connor Moore, et al.
Healthcare (Basel, Switzerland)|May 24, 2024
A Data-Driven Approach to Defining Risk-Adjusted Coding Specificity Metrics for a Large U.S. Dementia Patient CohortKaylla Richardson, Sankari Penumaka, Jaleesa Smoot, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1993
Phase I trial of subcutaneous interleukin-6 in patients with advanced malignanciesJ Weber, J C Yang, S L Topalian, et al.
The Cochrane Database of Systematic Reviews|December 14, 2016
Automated telephone communication systems for preventive healthcare and management of long-term conditionsPawel Posadzki, Nikolaos Mastellos, Rebecca Ryan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 1, 1996
Phase I trial of subcutaneous interleukin 3 in patients with refractory malignancy: hematological, immunological, and pharmacodynamic findingsR M Bukowski, T Olencki, H Gunn, et al.
Atherosclerosis|March 6, 2024
Estimating potential cardiovascular health benefits of improved population level control of LDL cholesterol through a twice-yearly siRNA-based approach: A simulation study of a health-system level interventionKausik K Ray, Laura H Gunn, Lorena Garcia Conde, et al.
Population Health Management|February 7, 2015
Evaluation of Diverse Community Asthma Interventions: Balancing Health Outcomes with Developing Community Capacity for Evidence-Based Program MeasurementLynn D Woodhouse, William C Livingood, Russ Toal, et al.
Pilot and Feasibility Studies|August 4, 2017
Balance Right in Multiple Sclerosis (BRiMS): a guided self-management programme to reduce falls and improve quality of life, balance and mobility in people with secondary progressive multiple sclerosis: a protocol for a feasibility randomised controlled trialH Gunn, J Andrade, L Paul, et al.
Pilot and Feasibility Studies|January 4, 2021
Balance Right in Multiple Sclerosis (BRiMS): a feasibility randomised controlled trial of a falls prevention programmeH Gunn, K N Stevens, S Creanor, et al.
Pageof 15

Showing results (121-130 of 146) with videos related to

Sort By:
Pageof 15
European Journal of Preventive Cardiology|June 23, 2021
Is the SMART risk prediction model ready for real-world implementation? A validation study in a routine care setting of approximately 380 000 individualsAilsa J McKay, Laura H Gunn, Brian A Ference, et al.
Diagnostics (Basel, Switzerland)|February 24, 2024
A Novel Method for Assessing Risk-Adjusted Diagnostic Coding Specificity for Depression Using a U.S. Cohort of over One Million PatientsAlexandra Glass, Nalander C Melton, Connor Moore, et al.
Healthcare (Basel, Switzerland)|May 24, 2024
A Data-Driven Approach to Defining Risk-Adjusted Coding Specificity Metrics for a Large U.S. Dementia Patient CohortKaylla Richardson, Sankari Penumaka, Jaleesa Smoot, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1993
Phase I trial of subcutaneous interleukin-6 in patients with advanced malignanciesJ Weber, J C Yang, S L Topalian, et al.
The Cochrane Database of Systematic Reviews|December 14, 2016
Automated telephone communication systems for preventive healthcare and management of long-term conditionsPawel Posadzki, Nikolaos Mastellos, Rebecca Ryan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 1, 1996
Phase I trial of subcutaneous interleukin 3 in patients with refractory malignancy: hematological, immunological, and pharmacodynamic findingsR M Bukowski, T Olencki, H Gunn, et al.
Atherosclerosis|March 6, 2024
Estimating potential cardiovascular health benefits of improved population level control of LDL cholesterol through a twice-yearly siRNA-based approach: A simulation study of a health-system level interventionKausik K Ray, Laura H Gunn, Lorena Garcia Conde, et al.
Population Health Management|February 7, 2015
Evaluation of Diverse Community Asthma Interventions: Balancing Health Outcomes with Developing Community Capacity for Evidence-Based Program MeasurementLynn D Woodhouse, William C Livingood, Russ Toal, et al.
Pilot and Feasibility Studies|August 4, 2017
Balance Right in Multiple Sclerosis (BRiMS): a guided self-management programme to reduce falls and improve quality of life, balance and mobility in people with secondary progressive multiple sclerosis: a protocol for a feasibility randomised controlled trialH Gunn, J Andrade, L Paul, et al.
Pilot and Feasibility Studies|January 4, 2021
Balance Right in Multiple Sclerosis (BRiMS): a feasibility randomised controlled trial of a falls prevention programmeH Gunn, K N Stevens, S Creanor, et al.
Pageof 15